decoded.report LIVE FROM SEC FILINGS
CASE FILE · OPENED JUST FOR YOU

BIOA

BioAge Labs, Inc.
LAST CLOSE… Pharmaceutical Preparations SHARES +28.0% · 12M CASH ~10 MO
51
ELEVATED
RISK INDEX
RED FLAGS 24 SHARE PRINTING 14 RUNWAY 8 CASH DRAIN 5 = 51/100. WHY THIS NUMBER, PIECE BY PIECE.

THE READ 28 red-flag mentions across this year's filings, led by dilution; share count jumped 28% in a year (holders are being diluted fast); roughly 10 months of cash at the current burn rate.

FLAGS DILUTION CASH WHAT CHANGED VERDICT INSIDERS OUTSIDE RECORDS
01

Red Flags

2025-10-13 → 2026-10-13

We read every document this company filed with the SEC this year and counted the classic danger phrases. Where wording can be misleading, we open the actual documents and separate real warnings from accounting boilerplate. Each hit links to the exact document.

Dilution (at the market offering) AT LEAST 28 REAL WARNINGS · 7 matching docS this year

An ATM lets the company print and sell new shares into the market any day it wants. Every print dilutes your slice.

EVIDENCE: [1] S-3/A FILED 2025-11-05 · [2] 10-Q FILED 2026-08-05 · [3] 424B5 FILED 2026-01-22 · [4] 424B5 FILED 2026-01-20 · [5] 10-Q FILED 2026-05-08

Reverse stock split CLEAN

A reverse split shrinks the share count to lift the price above $1. Repeat reverse splits are the classic death-spiral signature.

EVIDENCE: [1] 10-K FILED 2026-03-24

Going concern doubt SCAN UNAVAILABLE

Auditors flagged substantial doubt the company survives the next 12 months without new money.

Delisting / exchange risk 0 THIS YEAR · 2 ALL TIME

The exchange has threatened to kick the stock off. Delisting pressure usually ends in a reverse split or a fire-sale raise.

SOURCE: FULL-TEXT SEARCH OF THE COMPANY'S OFFICIAL SEC FILINGS. "REAL WARNINGS" = WE OPENED THE LINKED DOCUMENTS AND FILTERED PHRASES WRAPPED IN NEGATIONS, RESOLUTION LANGUAGE OR STANDARD CONTRACT TERMS. "AT LEAST" = MORE DOCUMENTS CARRY THE PHRASE THIS YEAR THAN WE COULD OPEN AND READ.

02

The Printing Press

How many shares exist, over time, exactly as the company reported in its own filings. In microcaps, a rising share count is how holders pay for everything: salaries, debts, and bad deals. Sudden collapses in the line are reverse splits, marked below.

35,848,738 shares · 2024-10-31 45,896,909 shares · 2026-07-31 LAST 12M: +28.0% AVG/YEAR SINCE 2024: +15.2%

SOURCE: THE COMPANY'S OWN REPORTED SHARE COUNTS ACROSS 8 FILINGS, STRAIGHT FROM SEC RECORDS

CHECKING OFFICIAL SPLIT RECORDS…

What this means for YOUR shares

Type how many shares you hold. The math is plain division on the company's own reported counts.

03

Cash Countdown

Cash in the bank against how fast the company burns it. When this hits zero, the next stop is usually a desperate raise at bad terms, and existing holders pay through dilution.

~10 MONTHS OF CASH AT THE CURRENT BURNBAR = SHARE OF A 24-MONTH WINDOW
10 MO
EST RUNWAY
cash ÷ monthly burn
$7.32M
MONTHLY BURN
operating cash deficit
$73.96M
CASH ON HAND
latest reported quarter
-69.4%
CASH CHANGE QoQ
latest two reported quarters
2024·92024·122025·32025·62025·92025·122026·32026·6
CASH OVER TIME, LAST 8 REPORTED QUARTERS $334.47M → $73.96M TREND: -77.9%

RUNWAY = CASH ON HAND ÷ MONTHLY CASH BURN. SIMPLE ARITHMETIC ON THE COMPANY'S OWN REPORTED NUMBERS, NOT A PROJECTION.

04

What the Newest Filing Changed

The latest filings, translated into holder impact. Every number cites its form, date and SEC link.

Shares outstanding +3.2%

Shares outstanding rose 44.45M to 45.90M (+3.2%) between 10-Q 2026-05-01 and 10-Q 2026-07-31 (dilution).

NOW: 45,896,909 as of 2026-07-31 (10-Q, filed 2026-08-05)

WAS: 44,452,734 as of 2026-05-01 (10-Q, filed 2026-05-08)

Cash and equivalents -69.4%

Cash and equivalents fell $241.78M to $73.96M (-$167.81M, -69.4%) between 10-Q 2026-03-31 and 10-Q 2026-06-30.

NOW: $73.96M as of 2026-06-30 (10-Q, filed 2026-08-05)

WAS: $241.78M as of 2026-03-31 (10-Q, filed 2026-05-08)

Total assets -0.2%

Total assets fell to $396.93M (from $397.65M, -0.2%) between 10-Q 2026-03-31 and 10-Q 2026-06-30.

NOW: $396.93M as of 2026-06-30 (10-Q, filed 2026-08-05)

WAS: $397.65M as of 2026-03-31 (10-Q, filed 2026-05-08)

Total liabilities +18.8%

Total liabilities rose to $22.02M (from $18.53M, +18.8%) between 10-Q 2026-03-31 and 10-Q 2026-06-30.

NOW: $22.02M as of 2026-06-30 (10-Q, filed 2026-08-05)

WAS: $18.53M as of 2026-03-31 (10-Q, filed 2026-05-08)

Revenue -11.6%

Revenue fell $2.77M to $2.45M (-11.6%) between the period ended 2026-03-31 and the period ended 2026-06-30 (10-Q).

NOW: $2.45M as of 2026-06-30 (10-Q, filed 2026-08-05)

WAS: $2.77M as of 2026-03-31 (10-Q, filed 2026-05-08)

Cash burn / runway

Monthly operating cash deficit ~$7.32M ($-43.31M over the period ended 2026-06-30 in 10-Q). Against $73.96M cash is roughly 0.8 years of runway (10 months).

NOW: $-43.31M as of 2026-06-30 (10-Q, filed 2026-08-05)

NO CRITICAL-ITEM 8-Ks ON FILE IN 24 MONTHS: NO BANKRUPTCY PAPERS, DELISTING NOTICES, AUDITOR CHANGES OR WITHDRAWN NUMBERS. SILENCE HERE IS THE GOOD KIND.

2024·62024·92025·32025·62025·92026·32026·6
QUARTERLY REVENUE, LAST 7 QUARTERS $0 → $2.45M

EACH BAR IS ONE REPORTED QUARTER. GREEN = MOST RECENT QUARTER GREW VS THE ONE BEFORE.

NO 8-K IN THE LAST 7 DAYS. SILENCE IS NOTED TOO.

05

The Verdict

SELL · HIGH CONFIDENCE

A rules-based reading of the cited filing facts: a range with reasons, never a prediction.

SELL
SCREENING VERDICT
HIGH confidence
$4.08-$4.08
FAIR VALUE BRACKET
book equity of $8.17/share at 0.5-1.0x
$5.56
LAST CLOSE
non-realtime

HOW THE BRACKET IS BUILT: BOOK EQUITY OF $8.17/SHARE AT 0.5-1.0X · MULTIPLES STRIPPED: UNDER A YEAR OF CASH AT THE CURRENT BURN, SO THE BRACKET CAPS AT WIND-DOWN CASH · CASH FLOOR: $1.61/SHARE IN A WIND-DOWN.

BASIS FOR

+1

Share count is stable-ish (+3.2% change between the last two reported quarters).

+2

Fair-value range anchored to cited facts: $4.08 to $4.08 per share.

AGAINST

−1

Cash of $73,964,000 funds only ~0.8 years of operating burn (that is a going-concern pressure without a raise).

−2

Revenue fell 11.6% period over period.

METHOD: DETERMINISTIC RULES OVER CITED SEC FILING FACTS: SHARE-COUNT CHANGE BETWEEN THE LAST TWO REPORTED QUARTERS (DILUTION), CASH-TO-BURN RUNWAY FROM THE MOST RECENT OPERATING CASH FLOW, PERIOD-OVER-PERIOD REVENUE GROWTH, AND A FAIR-VALUE RANGE ANCHORED TO CASH PER SHARE VS PRICE. THRESHOLDS ARE TUNABLE IN APP/VERDICT_ENGINE.PY. NOT A PREDICTION.

06

Insider Paper Trail

NET SELLING

Every time an officer, director or big owner trades shares, the law makes them file a Form 4 within two business days. We read the actual filings: who traded, what kind of trade, how big, at what price.

0
OPEN-MARKET BUYS
nobody is buying with their own cash
2
OPEN-MARKET SELLS
62,566 shares · ~$1.58M cashed out
16
GRANTS / AWARDS
119,868 new shares/options handed out: future dilution
2/2
SELLS ON 10B5-1 PLANS
every sale was pre-scheduled in advance: less alarming than a discretionary dump
2026-012026-022026-032026-042026-052026-06
ABOVE THE LINE: CASH BUYS BELOW THE LINE: CASH SELLS 6 MO: +$0 / -$509K

EACH MONTH SHOWS OPEN-MARKET DOLLAR FLOW PARSED FROM FORM 4 FILINGS. GRANTS AND OPTION PAPER ARE EXCLUDED: THIS IS REAL MONEY IN AND OUT.

DATEWHOACTION
2026-06-30 Barton Shane OPTION EXERCISE 4,290 @ $10.85 10B5-1 PLAN
2026-06-30 Barton Shane OPTION EXERCISE 4,000 @ $8.39 10B5-1 PLAN
2026-06-30 Barton Shane OPTION EXERCISE 4,065 @ $4.30 10B5-1 PLAN
2026-06-30 Barton Shane OPTION EXERCISE 7,861 @ $4.38 10B5-1 PLAN
2026-06-30 Barton Shane OPEN-MARKET SELL 20,216 @ $25.19 10B5-1 PLAN
2026-06-30 Barton Shane OPTION EXERCISE 4,290 OPTIONS/DERIVATIVE 10B5-1 PLAN
2026-06-30 Barton Shane OPTION EXERCISE 4,000 OPTIONS/DERIVATIVE 10B5-1 PLAN
2026-06-30 Barton Shane OPTION EXERCISE 4,065 OPTIONS/DERIVATIVE 10B5-1 PLAN
2026-06-30 Barton Shane OPTION EXERCISE 7,861 OPTIONS/DERIVATIVE 10B5-1 PLAN
2026-06-29 Barton Shane OPTION EXERCISE 9,301 @ $10.85 10B5-1 PLAN
2026-06-29 Barton Shane OPTION EXERCISE 7,261 @ $8.39 10B5-1 PLAN
2026-06-29 Barton Shane OPTION EXERCISE 8,958 @ $4.30 10B5-1 PLAN

PEOPLE WITH THE BEST INFORMATION ABOUT THIS COMPANY ARE SELLING MORE THAN THEY BUY. NOT PROOF OF ANYTHING: EXECUTIVES SELL FOR MANY REASONS. BUT AT MICROCAP SCALE, IT RARELY SMELLS GOOD. "10B5-1 PLAN" MEANS THE TRADE WAS SCHEDULED UNDER A PRE-SET TRADING PLAN, DISCLOSED IN THE FILING'S OWN FOOTNOTES: PRE-PLANNED SALES CARRY LESS SIGNAL THAN SPUR-OF-THE-MOMENT ONES. SOURCE: FORM 4 FILINGS, PARSED FROM THE SEC'S OWN XML, LAST 1 FILINGS.

07

Filing Timeline

The company's most recent SEC paperwork, newest first.

8-K 2026-10-02 0001193125-26-412300
SCHEDULE 13G/A 2026-08-14 0001172661-26-003686
10-Q 2026-08-05 0001193125-26-335407
8-K 2026-08-05 0001193125-26-335368
4 2026-07-01 0001836297-26-000005
144 2026-06-30 0001959173-26-004979

SOURCE: THE COMPANY'S SEC FILING INDEX

08

Outside the Filings

Public records that most investors never check, cross-checked against what the company claims. This is where shells slip up.

bioagelabs.com
WEB ADDRESS ON RECORD
registered 2015-03-30 · via Squarespace Domains II LLC
11.5 YRS OLD
DOMAIN AGE
old and consistent with an operating company: a good sign
2
OFFICIAL OFFERING DOCS · 12M
last one 2026-01-22: shares were actually sold to the market
2
SHELF REGISTRATIONS · 12M
paperwork filed to allow future share sales: future dilution waiting
0
BIG-OWNER TAKEOVER FILINGS · 12M
no outside investor has crossed the 5% disclosure line this year
PUBLIC FLOAT
shares actually tradable, vs held by insiders and big owners
SOLD SHORT
FINRA short interest: how many shares are bets against this company, and how many days of trading it would take to cover
CLEAR
US SANCTIONS SCREEN
company name checked against the official US sanctions list (19334 entries)
LEGAL IDENTITY (LEI)
every company that trades securities must carry a global legal identifier: status, parent chain and subsidiaries from the official registry
INSTITUTIONAL HOLDERS · 13F
quarterly institutional holdings filings scanned for this exact company name: which funds still report holding shares, from their own filings
SITE HISTORY
how long the company's website has been around, per the public web archive
CERT RECORD
public certificate logs date the company's web infrastructure: old and boring is good, brand-new is a tell
REGISTRANT HISTORY
old snapshots of public WHOIS pages: has the registered owner of this address changed hands
HOSTING + MAIL RECORDS
public DNS records: where the address is pointed and whether it can even receive mail

SOURCES: PUBLIC DOMAIN REGISTRATION RECORDS (FOUND IN THE COMPANY'S OWN FILING SIGNATURES) · THE COMPANY'S SEC FILING INDEX · OFFICIAL US SANCTIONS LIST · QUARTERLY 13F FILINGS VIA EDGAR FULL-TEXT SEARCH · LEGAL-IDENTITY, SITE-HISTORY, CERTIFICATE, REGISTRANT-HISTORY AND DNS SLOTS STREAM IN FROM FREE PUBLIC REGISTRIES WITHOUT BLOCKING THIS PAGE.

↳

Others Under The Scanner

Real visitors who opened this case file also checked these tickers. Derived only from on-site search and watchlist activity of the last 90 days: no tracking, no cookies.

09

Company Record

Legal nameBioAge Labs, Inc.
Fiscal year end1231
HQ5885 HOLLIS STREET, SUITE 370, EMERYVILLE, CA
Last periodic report2026-08-05 (10-Q, 69d ago)
Shares outstanding45,896,909 as of 2026-07-31 (10-Q)

SOURCE: THE COMPANY'S SEC FILING INDEX

+

Decode Another Ticker